Monoclonal antibodies are approved for specific indications and are available by prescription. Availability may vary depending on the country, healthcare system, and regulatory approvals. Access to monoclonal antibodies can also be influenced by factors such as cost, reimbursement policies, and healthcare provider recommendations.